The effect of rimantadine on the structure of model and biological membranes.
The action of the antiviral drug rimantadine on the structure of bilayer lipid membranes (BLM) and RBC membranes was investigated. Structural changes in BLM were recorded by ionophore conductivity changes and by changes in the third harmonic of capacity current signal due to lateral compression of BLM in an electric field. It was shown that the adsorption of rimantadine on BLM results in an increase in ionophore mobility in bilayer membranes of dioleolyllecithin (DOL) and common lipids of bovine brain (CL) and in a decrease in those of azolectin (A). Relative changes in the third harmonic signal also depend on the membrane composition and have different signs. The results may be explained by the rimantadine action on the lipid bilayer structure: "rigidification" of A-membranes and "fluidization" of BLM from DOL and CL. Structural reorganization of RBC membranes as investigated by the ability of the cells to enter a micropipette (inner diameter greater than or equal to 3 microns) thereby undergoing deformation. It was shown that rimantadine influences RBC deformability due to drug induced inhomogenous mechanical membrane properties. Also, rimantadine accelerated the process of artificially induced aggregation of erythrocytes. The relation of the effects on artificial and biological membranes, and the structural changes in the lipid phase of membrane are discussed.
Cherny
V V
VV
A.N. Frumkin Institute of Electrochemistry, Academy of Sciences, Moscow, USSR.
Paulitschke
M
M
Simonova
M V
MV
Hessel
E
E
Ermakov YuA
Sokolov
V S
VS
Lerche
D
D
Markin
V S
VS
D000218:Adamantane / Q000031:analogs & derivatives; D002449:Cell Aggregation / Q000187:drug effects; D004553:Electric Conductivity; D004907:Erythrocyte Deformability / Q000187:drug effects; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000502:physiology*; D004912:Erythrocytes / Q000166:cytology / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D008051:Lipid Bilayers; D008055:Lipids; D008433:Mathematics; D008560:Membrane Fluidity; D008564:Membrane Potentials; D008962:Models, Theoretical; D010713:Phosphatidylcholines; D010743:Phospholipids; D012299:Rimantadine / Q000494:pharmacology
D008051:Lipid Bilayers; D008055:Lipids; D010713:Phosphatidylcholines; D010743:Phospholipids; D012299:Rimantadine; C024990:asolectin; C017251:1,2-oleoylphosphatidylcholine; D000218:Adamantane